Ludwig Cancer Research engages leading scientists and clinicians in an integrated effort to understand and confront the challenge of cancer. The Oxford Branch is based at the University of Oxford, UK and benefits from excellent links with the global Ludwig Cancer Research and local Oxford research communities.
Ludwig Oxford Branch researchers are investigating all stages of cancer, from the risk of disease through to new treatment opportunities. Our research groups are interested in the signalling pathways that influence cancer initiation and progression, with a focus on infection, inflammation and cancer epigenetics. We aim to advance cancer prevention, early diagnosis and effective treatment. Find out more about the Ludwig Oxford research groups.
News
Vacancy: Research Assistant - AVATAR
8 May 2025
Publications
-
Delineating Mpl-dependent and -independent phenotypes of Jak2 V617F- positive MPNs in vivo.
Journal article
Papadopoulos N. et al, (2025), Blood
-
Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation
Journal article
Hosseini A. et al, (2025), Nature
-
MSP-tracker: A versatile vesicle tracking software tool used to reveal the spatial control of polarized secretion in Drosophila epithelial cells.
Journal article
Richens JH. et al, (2025), PLoS biology, 23
